Found: 3
Select item for more details and to access through your institution.
Cannabidiol (Epidyolex®) for severe behavioral manifestations in patients with tuberous sclerosis complex, mucopolysaccharidosis type III and fragile X syndrome: protocol for a series of randomized, placebo-controlled N-of-1 trials.
- Published in:
- BMC Psychiatry, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12888-023-05422-3
- By:
- Publication type:
- Article
Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).
- Published in:
- Journal of Autism & Developmental Disorders, 2018, v. 48, n. 7, p. 2278, doi. 10.1007/s10803-018-3478-0
- By:
- Publication type:
- Article
Child characteristics associated with child quality of life and parenting stress in Angelman syndrome.
- Published in:
- Journal of Intellectual Disability Research, 2024, v. 68, n. 3, p. 248, doi. 10.1111/jir.13106
- By:
- Publication type:
- Article